Abstract
CRISPR/Cas9-mediated glucocorticoid receptor knockout effectively enhances antitumor efficacy of ROR1 specific CAR-T cells in advanced adrenocortical carcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have